electroCore, Inc.
ECORNasdaqHealthcare · Electromedical & Electrotherapeutic Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $32.0M | $25.2M | $16.0M | $8.6M | $5.5M | $3.5M |
| Operating income | −$13.2M | −$12.2M | −$19.3M | −$22.9M | −$20.0M | −$24.7M |
| Net income | −$14.0M | −$11.9M | −$18.8M | −$22.2M | −$17.2M | −$23.5M |
| Total assets | $18.7M | $20.5M | $16.1M | $24.8M | $42.8M | $31.5M |
| Total liabilities | $20.4M | $12.9M | $8.7M | $7.7M | $6.2M | $7.9M |
| Equity | −$1.7M | $7.5M | $7.4M | $17.1M | $36.6M | $23.0M |
| EPS (diluted) | $-1.65 | $-1.59 | $-3.42 | $-4.69 | $-4.36 | — |
| Shares out. | 7.2M | 6.0M | 4.7M | 70.7M | 48.5M | 30.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −41.1%
- Net margin
- −43.6%
- Return on equity
- 817.2%
- Return on assets
- −74.8%
- Return on capital (ROCE)
- −179.7%
- Liabilities / assets
- 109.2%
- Debt / equity
- —
- Book value / share
- $-0.24
- Revenue growth (YoY)
- 27.2%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -36.67distress
- Accruals / assets
- −31.0%clean
- Beneish M-Score
- -4.37normal
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 4 warning● 3 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Hilve Holdings LtdPassive (13G)May 5, 2026
- Awm Investment Company, Inc.Passive (13G)Nov 13, 2025
- Theofilos Charles SteveActivist (13D)Jul 9, 2025
- Zhang TianyiPassive (13G)Jun 5, 2025
- Maz Partners LpActivist (13D)May 14, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 289,666 | 4.1 | -13.5% |
| Apr 30, 2026 | 334,857 | 8.4 | -1.9% |
| Apr 15, 2026 | 341,291 | 3.5 | +16.9% |
| Mar 31, 2026 | 291,996 | 4.2 | +11.3% |
| Mar 13, 2026 | 262,469 | 5.2 | +0.4% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 6, 2026
- Results of operationsMar 19, 2026
- Results of operations · Regulation FD disclosureJan 20, 2026
- Results of operationsNov 5, 2025
- Other material eventOct 3, 2025
- Director / officer change · Shareholder vote · Regulation FD disclosureSep 3, 2025
- Results of operationsAug 6, 2025
- Results of operationsMay 7, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.